South Korea - Export of Vaccines for Human Use
Since 2014, South Korea Export of Vaccines for Human Use decreased by 2% year on year. In 2019, the country was number 14 among other countries in Export of Vaccines for Human Use at $175,528,551.34. South Korea is overtaken by Spain, which was ranked number 13 with $218,990,604.74 and is followed by Singapore with $136,660,795.29. Belgium topped the ranking with $6,511,782,808.63 in 2019, that is a growth of 2.7% versus 2018. Ireland, United Kingdom and France respectively ranked number 2, 3 and 4 in this ranking. Nicaragua witnessed the best average annual growth at +356.4% per year, while Dominican Republic was the worst growing country at -87.1% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 175,528,551.34 |
| 2018 | 165,948,848.00 |
| 2017 | 183,490,880.00 |
| 2016 | 205,863,536.00 |
| 2015 | 199,138,016.00 |
Download all data from 1988 to 2019
How does South Korea rank in Export of Vaccines for Human Use?
| # | 115 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Belgium
|
6,511,782,808.63 | 2019 | +2.7 % | -9.2 % | View data | |
| 2 |
#2
Ireland
|
5,792,918,864.55 | 2019 | -0.9 % | +16.3 % | View data | |
| 13 |
#13
Spain
|
218,990,604.74 | 2019 | -5.5 % | +1.8 % | View data | |
| 14 |
#14
South Korea
|
175,528,551.34 | 2019 | +5.8 % | -2.0 % | View data | |
| 15 |
#15
Singapore
|
136,660,795.29 | 2019 | -1.9 % | +1.9 % | View data | |